Real-World Research Limited (RWR)
Real-World Research Limited was formed with the simple aim of making real-world research (RWR) studies easier to run. Capitalising on our previous success in this sector, CHCUK, which became a global leader in supplying regulatory and operational intelligence for non-interventional studies, we are now committed to utilising advances in technology to streamline real-world research and enable the industry to capitalise on the increasing value and importance of real-world evidence (RWE) driven by recent key regulatory bodies (FDA, EMA and MHRA).
Stuart is a global thought leader in the dynamic and rapidly changing world of RWE (Real World Evidence). With his background as a pharmacologist working on traditional pre-approval clinical trials, he became frustrated with the operational inefficiencies and support gaps for non-interventional (observational) studies. As a result, Stuart created CHCUK which became a global leader in supplying regulatory and operational intelligence for non-interventional studies.
As a passionate problem solver, Stuart and team have created a platform-based solution to address the regulatory and operational considerations for all types of real-world research studies.
Stuart is committed to utilising advances in technology to streamline real-world research and enable the industry to capitalise on the increasing value and importance of real-world evidence driven by recent key regulatory bodies (FDA, EMA and MHRA).
As an industry expert and thought leader, Stuart regularly provides RWE regulatory science advice, guidance and training to top 10 Pharma, Biotechs, Medical Device companies and CROs.
Ken is an outstanding drug development leader with 30+ years’ research experience within the Pharmaceutical and CRO industries. He has maintained an extensive knowledge of drug development processes in clinical research and project management, encompassing all development phases from pre-clinical through to post marketing research and across a wide therapeutic range including oncology (immuno-oncology), immunology, rare diseases, medical devices, neurology and psychiatry.
Alongside his wide therapeutic experience is a truly global expertise in operational delivering having worked in over 50 countries worldwide including the Americas (North and South), Europe, Asia-Pacific, Middle-East and North Africa and Sub-Saharan Africa.
Ken’s appetite, attitude, and focus allows him to execute projects in a way that makes others want to do more. His passion for people and love for technology and process make him excellent at leading teams and bringing excitement, vision and creative solutions to the complex world of RWE, medical devices and clinical trials.
Mark has founded five companies, filed multiple patents, advised more than 20 companies, whilst overseeing 7-digit revenue growth.
